ATE310088T1 - Behandlung und nachweis von staphylokokkeninfektionen - Google Patents

Behandlung und nachweis von staphylokokkeninfektionen

Info

Publication number
ATE310088T1
ATE310088T1 AT99913444T AT99913444T ATE310088T1 AT E310088 T1 ATE310088 T1 AT E310088T1 AT 99913444 T AT99913444 T AT 99913444T AT 99913444 T AT99913444 T AT 99913444T AT E310088 T1 ATE310088 T1 AT E310088T1
Authority
AT
Austria
Prior art keywords
treatment
detection
staphylococcal infections
same
staphylococcal
Prior art date
Application number
AT99913444T
Other languages
English (en)
Inventor
James Peter Burnie
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Application granted granted Critical
Publication of ATE310088T1 publication Critical patent/ATE310088T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AT99913444T 1998-03-31 1999-03-25 Behandlung und nachweis von staphylokokkeninfektionen ATE310088T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806762.2A GB9806762D0 (en) 1998-03-31 1998-03-31 Treatment and diagnosis of staphylococcal infections
PCT/GB1999/000939 WO1999050418A1 (en) 1998-03-31 1999-03-25 Treatment and diagnosis of staphylococcal infections

Publications (1)

Publication Number Publication Date
ATE310088T1 true ATE310088T1 (de) 2005-12-15

Family

ID=10829514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913444T ATE310088T1 (de) 1998-03-31 1999-03-25 Behandlung und nachweis von staphylokokkeninfektionen

Country Status (12)

Country Link
US (1) US6627730B1 (de)
EP (1) EP1068328B1 (de)
JP (1) JP4460156B2 (de)
AT (1) ATE310088T1 (de)
AU (1) AU752794B2 (de)
CA (1) CA2321960A1 (de)
DE (1) DE69928384T2 (de)
DK (1) DK1068328T3 (de)
ES (1) ES2248992T3 (de)
GB (1) GB9806762D0 (de)
NZ (1) NZ506196A (de)
WO (1) WO1999050418A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
CA2453937C (en) 2001-08-02 2013-05-14 University Of Sheffield Antigenic polypeptides
GB0127983D0 (en) 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
ES2472441T3 (es) * 2004-09-22 2014-07-01 Glaxosmithkline Biologicals S.A. Composición inmunog�nica para uso en vacunación contra estafilococos
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
US20080241127A1 (en) * 2006-12-29 2008-10-02 Dyax Corp. Methods of Making Passive Immunotherapies
CN102460172B (zh) * 2009-05-07 2015-03-04 生物梅里埃有限公司 用于抗微生物剂抗性测定的方法
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
US10918747B2 (en) 2015-07-30 2021-02-16 Vital Vio, Inc. Disinfecting lighting device
US9927097B2 (en) 2015-07-30 2018-03-27 Vital Vio Inc. Single diode disinfection
US10357582B1 (en) 2015-07-30 2019-07-23 Vital Vio, Inc. Disinfecting lighting device
US10835627B2 (en) 2017-12-01 2020-11-17 Vital Vio, Inc. Devices using flexible light emitting layer for creating disinfecting illuminated surface, and related method
US10309614B1 (en) 2017-12-05 2019-06-04 Vital Vivo, Inc. Light directing element
US10413626B1 (en) 2018-03-29 2019-09-17 Vital Vio, Inc. Multiple light emitter for inactivating microorganisms
US11639897B2 (en) 2019-03-29 2023-05-02 Vyv, Inc. Contamination load sensing device
US11541135B2 (en) 2019-06-28 2023-01-03 Vyv, Inc. Multiple band visible light disinfection
WO2021030748A1 (en) 2019-08-15 2021-02-18 Vital Vio, Inc. Devices configured to disinfect interiors
US11878084B2 (en) 2019-09-20 2024-01-23 Vyv, Inc. Disinfecting light emitting subcomponent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
CN1236063C (zh) * 1996-11-13 2006-01-11 纳幕尔杜邦公司 用重组生物体生产1,3－丙二醇的方法
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6300094B1 (en) * 1997-12-18 2001-10-09 Smithkline Beecham Corporation Polynucleotides encoding a novel ABC transporter

Also Published As

Publication number Publication date
EP1068328A1 (de) 2001-01-17
NZ506196A (en) 2002-02-01
US6627730B1 (en) 2003-09-30
ES2248992T3 (es) 2006-03-16
JP4460156B2 (ja) 2010-05-12
CA2321960A1 (en) 1999-10-07
WO1999050418A1 (en) 1999-10-07
DK1068328T3 (da) 2005-12-12
GB9806762D0 (en) 1998-05-27
EP1068328B1 (de) 2005-11-16
DE69928384D1 (de) 2005-12-22
JP2002509724A (ja) 2002-04-02
DE69928384T2 (de) 2006-06-01
AU752794B2 (en) 2002-10-03
AU3156699A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
DE60005953D1 (de) Stapelbare statische mischelemente
ATE255906T1 (de) Antikörper gegen cd40
ATE415979T1 (de) Behandlung mit anti-erbb2 antikörpern
ES2333598T5 (es) Proteinas quimericas del factor de coagulacion fc para tratar la hemofilia.
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ES2113891T3 (es) Anticuerpos monoclonales de raton.
ES2188927T3 (es) Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.
GB0008305D0 (en) Treatment of fungal infections
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69838214D1 (de) Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen
PT1095059E (pt) Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
ATE225172T1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
ATE357931T1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
NO20005548D0 (no) Mykobakterieinhibitorer
DE69601154D1 (de) Zubereitungen für die Behandlung von Hepatitis C
ATE209659T1 (de) Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren
DE69827800D1 (de) Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose
DE60134881D1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1068328

Country of ref document: EP